The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)

NDT Plus

Volumn 2, Issue 3, 2009, Pages 213-221

  Vanholder, Raymond ^a   Abramowicz, Daniel ^b   Cannata Andia, Jorge B ^c   Cocchi, Valentina ^d   Cochat, Pierre ^e   Covic, Adrian ^f   Eckardt, Kai Uwe ^g   Fouque, Denis ^h   Heimburger, Olof ^i,j   Jenkins, Simon ^k   MacLeod, Alison ^l   Lindley, Elisabeth ^m   Locatelli, Francesco ⁿ   London, Gérard ^o   Monros, Ana Marti I ^p   Spasovski, Goce ^q   Tattersall, James ^m   Van Biesen, Wim ^a   Wanner, Christoph ^r   Wiecek, Andrej ^s   Zoccali, Carmine ^t   more..

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d European Renal Association/European Dialysis and Transplantation Association   (United States)

^e HOSPICES CIVILS DE LYON   (France)

^f C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k Patient Representative   (United Kingdom)

^l UNIVERSITY OF ABERDEEN   (United Kingdom)

^m LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

ⁿ A MANZONI HOSPITAL   (Italy)

^o PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^p CHGUV Nephrology Department   (Spain)

^q University Clinical Center Skopje   (Macedonia)

^r UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^s MEDICAL UNIVERSITY OF SILESIA   (Poland)

^t Ospedali Riuniti e CNR IBIM   (Italy)

more..

Author keywords

ERBP; Guidelines

Indexed keywords

EUROPE; MEDICAL PRACTICE; MEDICAL SOCIETY; NEPHROLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 77953018733     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp035     Document Type: Review

References (32)

1. Woolf SH, Grol R, Hutchinson A et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-530
2. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15: 411-419
3. Coca SG, Krumholz HM, Garg AX et al. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296: 1377-1384
4. Vanbelleghem H, Vanholder R, Levin NW et al. The kidney disease: improving global outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int 2007; 71: 1054-1061
5. Eknoyan G, Lameire N, Barsoum R et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-1314
6. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? from European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-2166
7. KDIGO guideline for hepatitis C in CKD. Kidney Int 2009; 73(Suppl 109): S1-S99
8. Uhlig K, Macleod A, Craig J et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 70: 2058-2065
9. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
10. Locatelli F, Covic A, Eckardt KU et al. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 2009; 24: 348-354
11. Covic A, Abramowicz D, Bruchfeld A et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719-727
12. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
13. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
14. Phrommintikul A, Haas SJ, Elsik M et al. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007; 369: 381-388
15. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654
16. EBPG Expert Group on Renal Transplantation. European Best Practice Guidelines for Renal Transplantation (Part 1). Nephrol Dial Transplant 2000; 15(Suppl 7): 1-85
17. EBPG Expert Group on Renal Transplantation. European Best Practice Guidelines for Renal Transplantation (Part 2). Nephrol Dial Transplant 2002; 17(Suppl 4): 1-67
18. The EBPG Expert Group on Haemodialysis. European Best Practice Guidelines for Haemodialysis (Part 1). Nephrol Dial Transplant 2002;17(Suppl 7): 1-111
19. Fouque D, Vennegoor M, ter WP et al. EBPG Guideline on Nutrition. Nephrol Dial Transplant 2007; 22(Suppl 2): ii45-ii87
20. Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol Dial Transplant 2007; 22(Suppl 2): ii88-ii117
21. Tattersall J, Martin-Malo A, Pedrini L et al. EBPG Guideline on Dialysis Strategies. Nephrol Dial Transplant 2007; 22(Suppl 2): ii5-ii21
22. Kooman J, Basci A, Pizzarelli F et al. EBPG Guideline on Haemodynamic Instability. Nephrol Dial Transplant 2007; 22(Suppl 2): ii22-ii44
23. Chan DT, Irish AB, Dogra GK et al. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 2008; 196: 823-834
24. Cooper BA, Branley P, Bulfone L et al. The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int 2004; 24: 176-181
25. European Best Practice Guidelines for Peritoneal Dialysis. Nephrol Dial Transplant 2005; 20(Suppl 9): 1-37
26. http://kdigo.org/nephrology-guideline-database/guideline-coordination- initiative.php
27. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997; 127: 380-387
28. Van Biesen W, Verbeke F, Vanholder R. An infallible recipe? A story of cinnamon, souffle and meta-analysis. Nephrol Dial Transplant 2008; 23: 2729-2732
29. Jager KJ, Zoccali C. QUality European STudies (QUEST)-a step forward in the quality of RRT care. Nephrol Dial Transplant 2005; 20: 2005-2006
30. Del Vecchio L, Locatelli F, Martins PM et al. The QUEST initiative anemia study in ESRD: rationale and study protocol. J Nephrol 2007; 20: 547-553
31. Van Biesen W, Locatelli F, Martins PM et al. The QUEST initiative anemia study in transplant patients: rationale and study protocol. J Nephrol 2007; 20: 543-546
32. Couchoud C, Jager KJ, Tomson C et al. Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. Nephrol Dial Transplant 2009; in press